Please use this identifier to cite or link to this item:
http://dspace.mediu.edu.my:8181/xmlui/handle/10261/3235| Title: | Treatment of disorders caused by changes in neurone axonal development Tratamiento de enfermedades causadas por alteraciones del desarrollo axonal de neuronas |
| Keywords: | Neuregulin 1 NRG1 Epidermal growth factor Axonal development Neurones |
| Description: | Filing Date: 2007-04-03.-- Priority Data: ES P200600882 (2006-04-05). [English] The invention relates to the use of a peptide that comprises the amino acid sequence of the epidermal growth factor-like domain (EGF domain) of neuregulin 1 (NRG1), or a functionally equivalent variant or fragment thereof, or of a polynucleotide that codes for said peptide or functionally equivalent fragment or variant, or of a compound that induces the production and/or activity of said NRG1, in the preparation of a pharmaceutical composition for treating disorders caused by changes in the axonal development of neurones in the nervous system. [Español] La invención se relaciona, en general, con el tratamiento de enfermedades causadas por alteraciones del desarrollo axonal de las neuronas del sistema nervioso, particularmente en humanos, basado en el empleo de la neuregulina 1 (NRG1), o una variante o fragmento funcionalmente equivalente de la misma, o de un polinucleótido que codifica dicha proteína, variante o fragmento funcionalmente equivalente, o de un compuesto que potencia la producción y/o actividad de dicha NRG1. Peer reviewed |
| URI: | http://dspace.mediu.edu.my:8181/xmlui/handle/10261/3235 |
| Other Identifiers: | International Publication Number: WO 2007/113361 A1 http://hdl.handle.net/10261/3235 |
| Appears in Collections: | Digital Csic |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.